An attempt on removal of haloperidol in plasma by use of anti-haloperidol immunoadsorbent
Nagao, M.; Kanamori, M.; Takatori, T.; Terazawa, K.; Gotouda, H.
Nihon Hoigaku Zasshi 41(3): 232-235
1987
ISSN/ISBN: 0047-1887 PMID: 3682297 Document Number: 303840
Document emailed within 1 workday
Related Documents
Leff, J.P.; Tress, K.H. 1986: The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate International Clinical Psychopharmacology 1(Suppl 1): 27-40Goyot, C.; Debray, Q.; Dugas, M.; Guay, C.; Giraud, J.; Grenier, J. 1985: Haloperidol. Plasma monitoring and hormonal effects of treatment Pathologie-Biologie 33(10): 999-1004
Morselli, P.L.; Zarifian, E.; Cuche, H.; Bianchetti, G.; Cotterau, M.J.; Deniker, P. 1980: Haloperidol plasma level monitoring in psychiatric patients Advances in Biochemical Psychopharmacology 24: 529-536
Dugas, M.; Zarifian, E.; Le Heuzey, M.F.; Regnier, N.; Durand, G.; Bianchetti, G.; Morselli, P.L. 1982: Plasma level monitoring of psychotropic drugs in children. I-Haloperidol La Nouvelle Presse Medicale 11(29): 2201-2204
Potkin, S.G.; Shen, Y.C.; Zhou, D.F.; Pardes, H.; Shu, L.; Phelps, B.; Poland, R. 1985: Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data Psychopharmacology Bulletin 21(1): 59-61
Altamura, A.C.; Buccio, M.; Colacurcio, F.; Colombo, G.; Terzi, A. 1986: Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol Acta Neurologica 8(1): 19-26
Davis, J.M.; Ericksen, S.E.; Hurt, S.; Chang, S.S.; Javaid, J.I.; Dekirmenjian, H.; Casper, R. 1985: Haloperidol plasma levels and clinical response: basic concepts and clinical data Psychopharmacology Bulletin 21(1): 48-51
Sakamoto, N.; Sakamoto, Y.; Kawano, J.; Uehara, M. 1995: Haloperidol Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 938-941
Janssen, P.A. 1979: Psychopharmacology of haloperidol Acta Psiquiatrica y Psicologica de America Latina 25(4): 307-316
Filippa, R.; Toso, A.; Cordero, J.; Olivos, Y. 1976: Haloperidol poisoning Revista Chilena de Pediatria 47(5-6): 369-371
Weddington, W.W.; Leventhal, B.L. 1982: Malicious abuse of haloperidol Journal of Clinical Psychiatry 43(10): 434
Mickle, J. 1998: The use of haloperidol to treat nausea Oncology Nursing Forum 25(8): 1309
Barnaulov, O.D.; Bondarev, R.P. 1976: Use of haloperidol by the emergency team Terapevticheskii Arkhiv 48(4): 51-55
Pufal, E.; Piotrowski, P.ła. 2006: Determination of haloperidol in fingernail/toenails by LC-ESI-Ms Archiwum Medycyny Sadowej i Kryminologii 56(3): 187-190
Reggio, A.; Condorelli, D.F.; De Simone, D.; Giammona, G.; Maccagnano, C.; Panico, A.M.; Tigano, G. 1981: Hyperprolactinemia and catalepsy induced by haloperidol Bollettino della Societa Italiana di Biologia Sperimentale 57(16): 1655-1659
López-Valdés, J.C.és. 2017: Haloperidol poisoning in pediatric patients Gaceta Medica de Mexico 153(1): 125-128
Lagomarsino, A.J. 1987: Haloperidol decanoate in psychotic patients Acta Psiquiatrica y Psicologica de America Latina 33(3): 181
Giorgobiani, I.B.; Kitiashvili, S.A. 2005: The pharmacokinetic effect of haloperidol on DA receptors Georgian Medical News 120: 68-70
Amielańczyk, W. 1973: Delirious syndrome following administration of haloperidol Psychiatria Polska 7(2): 218-221
Forsman, A.O. 1978: Individual variability in the haloperidol response Acta Psiquiatrica y Psicologica de America Latina 24(2): 149-153